Cholesterol efflux and cardiovascular outcomes - Prof. Michael Gibson
Listen to Prof Michael Gibson as he explores the association between cholesterol efflux and adverse CV events. He also discusses the potential of cholesterol efflux as a novel therapeutic target to improve outcomes for patients with CV disease.
Prof. C. Michael Gibson